PMC:7600245 / 20634-21986
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T91 | 54-61 | Body_part | denotes | adenine | http://purl.org/sig/ont/fma/fma82774 |
T92 | 76-86 | Body_part | denotes | nucleotide | http://purl.org/sig/ont/fma/fma82740 |
T93 | 183-186 | Body_part | denotes | DNA | http://purl.org/sig/ont/fma/fma74412 |
T94 | 306-311 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T95 | 517-527 | Body_part | denotes | intestinal | http://purl.org/sig/ont/fma/fma7199 |
T96 | 577-582 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T77 | 808-817 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T78 | 1157-1165 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T79 | 1168-1177 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T80 | 1310-1318 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T188 | 110-120 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activation |
T189 | 130-131 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T190 | 221-231 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activation |
T191 | 306-311 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T192 | 315-316 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T193 | 386-388 | http://purl.obolibrary.org/obo/CLO_0008922 | denotes | S2 |
T194 | 386-388 | http://purl.obolibrary.org/obo/CLO_0050052 | denotes | S2 |
T195 | 517-527 | http://purl.obolibrary.org/obo/UBERON_0000160 | denotes | intestinal |
T196 | 517-527 | http://www.ebi.ac.uk/efo/EFO_0000834 | denotes | intestinal |
T197 | 577-582 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T198 | 949-953 | http://purl.obolibrary.org/obo/CLO_0001185 | denotes | 2018 |
T199 | 1056-1060 | http://purl.obolibrary.org/obo/CLO_0001185 | denotes | 2018 |
T200 | 1122-1123 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T201 | 1200-1201 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T268 | 10-31 | Chemical | denotes | tenofovir alafenamide | http://purl.obolibrary.org/obo/CHEBI_90926 |
T269 | 10-19 | Chemical | denotes | tenofovir | http://purl.obolibrary.org/obo/CHEBI_134504|http://purl.obolibrary.org/obo/CHEBI_63625|http://purl.obolibrary.org/obo/CHEBI_63716 |
T272 | 33-40 | Chemical | denotes | Vemlidy | http://purl.obolibrary.org/obo/CHEBI_90923 |
T273 | 54-61 | Chemical | denotes | adenine | http://purl.obolibrary.org/obo/CHEBI_16708 |
T274 | 76-86 | Chemical | denotes | nucleotide | http://purl.obolibrary.org/obo/CHEBI_36976 |
T275 | 144-153 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
T276 | 183-186 | Chemical | denotes | DNA | http://purl.obolibrary.org/obo/CHEBI_16991 |
T277 | 239-243 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T278 | 367-377 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
T279 | 386-388 | Chemical | denotes | S2 | http://purl.obolibrary.org/obo/CHEBI_29387 |
T280 | 422-429 | Chemical | denotes | prodrug | http://purl.obolibrary.org/obo/CHEBI_50266 |
T281 | 454-461 | Chemical | denotes | prodrug | http://purl.obolibrary.org/obo/CHEBI_50266 |
T282 | 877-890 | Chemical | denotes | emtricitabine | http://purl.obolibrary.org/obo/CHEBI_31536 |
T283 | 892-899 | Chemical | denotes | Descovy | http://purl.obolibrary.org/obo/CHEBI_133007 |
T284 | 924-937 | Chemical | denotes | emtricitabine | http://purl.obolibrary.org/obo/CHEBI_31536 |
T285 | 956-969 | Chemical | denotes | emtricitabine | http://purl.obolibrary.org/obo/CHEBI_31536 |
T286 | 974-985 | Chemical | denotes | rilpivirine | http://purl.obolibrary.org/obo/CHEBI_68606 |
T287 | 987-994 | Chemical | denotes | Odefsey | http://purl.obolibrary.org/obo/CHEBI_133010 |
T288 | 1007-1016 | Chemical | denotes | darunavir | http://purl.obolibrary.org/obo/CHEBI_367163 |
T289 | 1017-1027 | Chemical | denotes | cobicistat | http://purl.obolibrary.org/obo/CHEBI_72291 |
T290 | 1032-1045 | Chemical | denotes | emtricitabine | http://purl.obolibrary.org/obo/CHEBI_31536 |
T291 | 1079-1092 | Chemical | denotes | emtricitabine | http://purl.obolibrary.org/obo/CHEBI_31536 |
T292 | 1097-1118 | Chemical | denotes | tenofovir alafenamide | http://purl.obolibrary.org/obo/CHEBI_90926 |
T293 | 1097-1106 | Chemical | denotes | tenofovir | http://purl.obolibrary.org/obo/CHEBI_134504|http://purl.obolibrary.org/obo/CHEBI_63625|http://purl.obolibrary.org/obo/CHEBI_63716 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T39 | 165-178 | http://purl.obolibrary.org/obo/GO_0003968 | denotes | transcriptase |
T40 | 165-178 | http://purl.obolibrary.org/obo/GO_0003899 | denotes | transcriptase |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T152 | 0-216 | Sentence | denotes | Likewise, tenofovir alafenamide (Vemlidy; 2016) is an adenine-based acyclic nucleotide analog that, following activation, acts as a competitive inhibitor of reverse transcriptase and DNA chain elongation termination. |
T153 | 217-395 | Sentence | denotes | The activation of the drug is, however, different and it usually takes place in infected cells by a series of bio-transformations similar to those of remdesivir (Figure S2) [67]. |
T154 | 396-612 | Sentence | denotes | The main advantage of the prodrug, relative to the former prodrug, is that it increases the drug’s oral bioavailability, intestinal diffusion, selectivity of targeting the infected cells, and intracellular half-life. |
T155 | 613-694 | Sentence | denotes | It also decreases the potential renal toxicity of the monophosphate intermediate. |
T156 | 695-755 | Sentence | denotes | Tenofovir alafenamide was first approved in 2016 by the U.S. |
T157 | 756-823 | Sentence | denotes | FDA and is prescribed for the oral treatment of HBV infection [68]. |
T158 | 824-1062 | Sentence | denotes | It is also available in many other combinations with emtricitabine (Descovy; 2016), bictegravir and emtricitabine (Biktarvy; 2018), emtricitabine and rilpivirine (Odefsey; 2016), and darunavir/cobicistat and emtricitabine (Symtuza; 2018). |
T159 | 1063-1352 | Sentence | denotes | The efficacy of emtricitabine and tenofovir alafenamide as a prophylactic combination against SARS-CoV-2 infection is being evaluated in a large randomized, double-blind, controlled with placebo clinical trial for health care providers exposed to COVID-19 patients (NCT04405271; n = 1378). |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
564 | 1319-1327 | Species | denotes | patients | Tax:9606 |
565 | 10-31 | Chemical | denotes | tenofovir alafenamide | MESH:C442442 |
566 | 54-61 | Chemical | denotes | adenine | MESH:D000225 |
567 | 367-377 | Chemical | denotes | remdesivir | MESH:C000606551 |
568 | 667-680 | Chemical | denotes | monophosphate | |
569 | 695-716 | Chemical | denotes | Tenofovir alafenamide | MESH:C442442 |
570 | 877-890 | Chemical | denotes | emtricitabine | MESH:D000068679 |
571 | 908-919 | Chemical | denotes | bictegravir | MESH:C000620396 |
572 | 924-937 | Chemical | denotes | emtricitabine | MESH:D000068679 |
573 | 956-969 | Chemical | denotes | emtricitabine | MESH:D000068679 |
574 | 974-985 | Chemical | denotes | rilpivirine | MESH:D000068696 |
575 | 1007-1016 | Chemical | denotes | darunavir | MESH:D000069454 |
576 | 1017-1027 | Chemical | denotes | cobicistat | MESH:D000069547 |
577 | 1032-1045 | Chemical | denotes | emtricitabine | MESH:D000068679 |
578 | 1079-1092 | Chemical | denotes | emtricitabine | MESH:D000068679 |
579 | 1097-1118 | Chemical | denotes | tenofovir alafenamide | MESH:C442442 |
580 | 297-305 | Disease | denotes | infected | MESH:D007239 |
581 | 568-576 | Disease | denotes | infected | MESH:D007239 |
582 | 645-659 | Disease | denotes | renal toxicity | MESH:D007674 |
583 | 804-817 | Disease | denotes | HBV infection | MESH:D006509 |
584 | 1157-1177 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 |
585 | 1310-1318 | Disease | denotes | COVID-19 | MESH:C000657245 |